BeiGene
BGNE
#955
Rank
C$29.15 B
Marketcap
$266.50
Share price
0.49%
Change (1 day)
11.92%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $581.65 CAD on 2021-09-17

Lowest end of day price: $34.60 CAD on 2016-02-12

Stock price history of BeiGene from 2016 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.44-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.48-3.37%๐Ÿ‡บ๐Ÿ‡ธ USA